Prucalopride is a selective 5-HT4 receptor agonist belonging to the dihydrobenzofurancarboxamide class, indicated for the treatment of chronic idiopathic constipation by stimulating colonic motility. This… Read more














































Prucalopride is a selective 5-HT4 receptor agonist belonging to the dihydrobenzofurancarboxamide class, indicated for the treatment of chronic idiopathic constipation by stimulating colonic motility. This category includes a comprehensive range of reference standards, such as the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these specialized materials for analytical testing, impurity profiling, and method validation to ensure drug quality and regulatory compliance. By utilizing these structurally characterized degradation products, synthetic intermediates, and labelled standards, researchers can perform accurate identification and quantification throughout the drug development and manufacturing lifecycle. These high-quality reference materials support rigorous stability studies and quality control processes, facilitating reliable analysis in accordance with international guidelines for pharmaceutical assessment and safety.